Ditchcarbon
  • Contact
  1. Organizations
  2. Allergan, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated a month ago

Allergan, Inc.

Company website

Allergan, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1948, the company has established itself as a leader in medical aesthetics, eye care, and neuroscience, with significant operations across North America, Europe, and Asia. Allergan is renowned for its innovative products, including the iconic Botox, which revolutionised cosmetic treatments, and a diverse portfolio of therapeutic solutions. The company’s commitment to research and development has led to numerous breakthroughs, solidifying its market position as a trusted provider of advanced healthcare solutions. With a focus on enhancing patient outcomes, Allergan continues to achieve notable milestones, making it a key player in the ever-evolving pharmaceutical landscape.

DitchCarbon Score

How does Allergan, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

65

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Allergan, Inc.'s score of 65 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Let us know if this data was useful to you

Allergan, Inc.'s reported carbon emissions

Inherited from AbbVie Inc.

Allergan, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is a current subsidiary of AbbVie Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. Allergan's climate initiatives are aligned with those of AbbVie Inc., which has set various reduction targets and participates in industry-standard climate initiatives. However, specific reduction targets or achievements for Allergan itself have not been disclosed. The company is involved in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are managed at the parent level. As a subsidiary, Allergan's climate commitments and performance metrics are likely influenced by AbbVie Inc.'s overarching sustainability strategies. This includes a focus on reducing Scope 1, 2, and 3 emissions, although specific figures for Allergan are not provided. In summary, while Allergan, Inc. does not present its own emissions data or specific reduction targets, it is part of a corporate family that is actively engaged in climate commitments through AbbVie Inc.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
402,448,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Allergan, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Allergan, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Allergan, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Fresenius Medical Care Holdings, Inc.

US
•
Health and social work services (85)
Updated 13 days ago

Alcon Laboratories, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Pharmacosmos

DK
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

AMAG Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Beiersdorf

DE
•
Other business services (74)
Updated about 1 hour ago

Synthes Inc.

US
•
Health and social work services (85)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy